Maine Medicine Weekly Update - April 16, 2021  (Plain Text Version)

Return to Graphical Version

 

In this issue:
•  Maine Medical Association Statement on Johnson & Johnson COVID-19 Vaccine Pause
•  FDA Update & Statement on Johnson & Johnson COVID-19 Vaccine Pause Recommendation
•  Thrombotic Thrombocytopenia & J&J COVID Vaccine Response from the Manufacturer
•  Over 30 Percent of US Adults Fully Vaccinated, Maine Leads the Nation
•  Maine CDC COVID-19 Update for Clinicians with Stephen Sears, MD
•  Clinical Updates and Guidance Related to COVID-19
•  Medicare FFS Claims: 2% Payment Adjustment (Sequestration) Suspended Through December
•  MaineCare Updates: Upcoming Accountable Communities Public Webinar & Primary Care 2.0 Presentation Available Online
•  HealthCare Dive: Urgent Care Centers Draw Some ER Visits but Associated with Higher Spending Overall
•  Webinar for Medical Students April 22: So You Are Employed, Now What?
•  Next MMA Legislative Call Will Be Wednesday, April 21st
•  Maine Community Action Partnership is Working for a Successful Vaccine Roll Out for All
•  Maine Medical Association & ActionPPE Partner Again; This Time for FDA Approved Rapid Antigen Tests
•  A Message from Maine Responds: Volunteer Opportunity
MAINE LEGISLATURE
•  Maine Legislature Week 14 Update
•  Maine Legislature Public Hearings, Work Sessions & New Bills
UPCOMING EVENTS
•  Upcoming Specialty Society Meetings
•  Maine CDC Physicians To Host Regular Clinician COVID Vaccine Info Sessions
•  "Prescribing to Reduce Opioid Overdose Risk: How to Impact the Epidemic Within the Pandemic"
•  NAMI Maine Workshops in May & June: Suicide Prevention & Management for Clinical Staff
•  AAP EQIPP Course: Immunizations - Strategies for Success (for RURAL Health Providers)
•  New Maine AAP Educational Webinar Series
HEALTHCARE EMPLOYMENT OPPORTUNITIES
•  Nurse Practitioner
•  Executive Director
•  Medical Director - ME License Required
•  Practice Administrator
•  Physician
•  Psychiatric Nurse Practitioner

 

"Prescribing to Reduce Opioid Overdose Risk: How to Impact the Epidemic Within the Pandemic"

Join the Maine Independent Clinical Information Service (MICIS), in partnership with the Maine Medical Association Center for Quality Improvement (MMA-CQI) for  "Prescribing to Reduce Opioid Overdose Risk: how to impact the epidemic within the pandemic".

 


Join the Maine Independent Clinical Information Service (MICIS), in partnership with the Maine Medical Association Center for Quality Improvement (MMA-CQI), on Tuesday April 27, 2021, from 12 – 1 p.m.  for "Prescribing to Reduce Opioid Overdose Risk: how to impact the epidemic within the pandemic" 

Overdoses in Maine increased 32% in 2020. While the primary focus of the country has been on a novel viral pandemic, the opioid pandemic has worsened. Prescribers can make a significant impact on the crisis by attending to five areas of prescribing. We hope you can join us! 

After attending this webinar, participants will:

1. Understand risk reduction in the context of opioid prescribing

2. Obtain familiarity with the benefits of buprenorphine for opioid use disorder

3. Describe recommendations for naloxone prescribing to increase patient safety

To register please navigate to: https://zoom.us/webinar/register/WN_Rg9W5-VjQaySSkaaTvUU8w